The Deal - Dealmaking Insights & Analysis

Activism

New Buyback Reporting Rules May Expose Deal Talks

By Ronald Orol

Published: May 25th, 2023

New rules from the SEC requiring more detailed disclosures on share repurchases by insiders could provide a window into confidential information about dealmaking for activists and other shareholders.

Activism

Activist Investing Today: EY’s Hunker Eyes 2023 Proxy Season

By Ronald Orol

Published: May 24th, 2023

The shareholder activism defense leader at Ernst & Young explains why ESG proponents and second-tier activists may be reticent to launch director contests, while brand-name insurgents can ‘weather the storm.’

M&A

Drinks With The Deal: Debevoise's Levitsky on Journey From Public Service to Private Practice

By David Marcus

Published: May 18th, 2023

Jonathan Levitsky, an M&A and PE partner at Debevoise & Plimpton, discusses clerking on the Supreme Court, working on the Kosovo peace accords and transitioning to an M&A and PE practice.

M&A

Deal Diary: TPG Turns to Weil on Angelo Gordon Deal

By David Marcus

Published: May 16th, 2023

TPG relies on Weil, Davis Polk, Shearman, Cleary, Ardea, JPM and Morgan Stanley on a $2.7 billion deal for Angelo Gordon, which uses Paul Weiss, Goldman and Piper Sandler.

Activism

Resurgence of Hostile Bids Provides Insurgents Fodder

By Ronald Orol

Published: May 16th, 2023

M&A

Drinks With The Deal: Hunton's Kennedy Talks Restrictive Covenants

By David Marcus

Published: May 4th, 2023

In the most recent Drinks With The Deal, Jim Kennedy, an M&A partner at Hunton Andrews Kurth, discusses recent Delaware decisions on restrictive covenants.